General Information of the Protein
Protein ID
PT02202
Protein Name
Poly [ADP-ribose] polymerase tankyrase-1
Secondarily
Protein Name
ADP-ribosyltransferase diphtheria toxin-like 5
Poly [ADP-ribose] polymerase 5A
Protein poly-ADP-ribosyltransferase tankyrase-1
TNKS-1
TRF1-interacting ankyrin-related ADP-ribose polymerase
Tankyrase I
Tankyrase-1
Gene Name
TNKS
Secondarily
Gene Name
PARP5A
PARPL
TIN1
TINF1
TNKS1
Sequence
MAASRRSQHHHHHHQQQLQPAPGASAPPPPPPPPLSPGLAPGTTPASPTASGLAPFASPRHGLALPEGDGSRDPPDRPRSPDPVDGTSCCSTTSTICTVAAAPVVPAVSTSSAAGVAPNPAGSGSNNSPSSSSSPTSSSSSSPSSPGSSLAESPEAAGVSSTAPLGPGAAGPGTGVPAVSGALRELLEACRNGDVSRVKRLVDAANVNAKDMAGRKSSPLHFAAGFGRKDVVEHLLQMGANVHARDDGGLIPLHNACSFGHAEVVSLLLCQGADPNARDNWNYTPLHEAAIKGKIDVCIVLLQHGADPNIRNTDGKSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVTELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDTLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGNEAVQQILSESTPIRTSDVDYRLLEASKAGDLETVKQLCSSQNVNCRDLEGRHSTPLHFAAGYNRVSVVEYLLHHGADVHAKDKGGLVPLHNACSYGHYEVAELLVRHGASVNVADLWKFTPLHEAAAKGKYEICKLLLKHGADPTKKNRDGNTPLDLVKEGDTDIQDLLRGDAALLDAAKKGCLARVQKLCTPENINCRDTQGRNSTPLHLAAGYNNLEVAEYLLEHGADVNAQDKGGLIPLHNAASYGHVDIAALLIKYNTCVNATDKWAFTPLHEAAQKGRTQLCALLLAHGADPTMKNQEGQTPLDLATADDIRALLIDAMPPEALPTCFKPQATVVSASLISPASTPSCLSAASSIDNLTGPLAELAVGGASNAGDGAAGTERKEGEVAGLDMNISQFLKSLGLEHLRDIFETEQITLDVLADMGHEELKEIGINAYGHRHKLIKGVERLLGGQQGTNPYLTFHCVNQGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Transferase
Function
Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking (PubMed:10988299, PubMed:11739745, PubMed:16076287, PubMed:19759537, PubMed:21478859, PubMed:22864114, PubMed:23622245, PubMed:25043379). Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation (PARsylation) of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP-ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation (PubMed:19759537, PubMed:21478859). Also mediates PARsylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination (PubMed:21478859). Mediates PARsylation of TERF1, thereby contributing to the regulation of telomere length (PubMed:11739745). Involved in centrosome maturation during prometaphase by mediating PARsylation of HEPACAM2/MIKI (PubMed:22864114). May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles (PubMed:10988299). May be involved in spindle pole assembly through PARsylation of NUMA1 (PubMed:16076287). Stimulates 26S proteasome activity (PubMed:23622245).
    Show/Hide
Uniprot ID
Primary ID:
O95271

Secondarily ID:
O95272
Q4G0F2
Q59FX0
    Show/Hide
Ensembl ID
ENSG00000173273
HGNC ID
HGNC:11941
Subcellular Location
Cytoplasm
Golgi apparatus membrane
Cytoplasm
Cytoskeleton
Microtubule organizing center
Centrosome
Nucleus
Nuclear pore complex
Chromosome
Telomere
Cytoplasm
Cytoskeleton
Spindle pole
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0508441
(4-pyrimidin-4-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C23H20N10O
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0154599
(4-pyrimidin-2-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C23H20N10O
 1
1
IC50 = 19.95 nM
   TI
   LI
   LO
   TS
CP0154554
[4-(1-methylimidazole-4-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H22N10O2
 1
1
IC50 = 31.62 nM
   TI
   LI
   LO
   TS
CP0458446
(4-pyridin-3-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H21N9O
 1
1
IC50 = 63.1 nM
   TI
   LI
   LO
   TS
CP0454432
N-methyl-N-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]acetamide
   Show/Hide
C17H15N7O
 1
1
IC50 = 79.43 nM
   TI
   LI
   LO
   TS
CP0539024
N-(2-methoxyethyl)-N-methyl-4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzamide
   Show/Hide
C19H19N7O2
 1
1
IC50 = 79.43 nM
   TI
   LI
   LO
   TS
CP0447057
1-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]pyrrolidin-2-one
   Show/Hide
C18H15N7O
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0454433
4-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]morpholin-3-one
   Show/Hide
C18H15N7O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0454455
[4-(1-methylpyrazole-3-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H22N10O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0492107
(4-pyridin-2-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H21N9O
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0432544
(4-pyridin-4-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H21N9O
 1
1
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0462220
1-[4-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoyl]piperazin-1-yl]ethanone
   Show/Hide
C21H20N8O2
 1
1
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0468722
[4-(1H-pyrazole-5-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C23H20N10O2
 1
1
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0118849
morpholin-4-yl-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C19H17N7O2
 1
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS
CP0154596
N-(4-propan-2-ylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C17H16N6
 1
1
IC50 = 199.53 nM
   TI
   LI
   LO
   TS
CP0558598
oxan-4-yl-[4-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoyl]piperazin-1-yl]methanone
   Show/Hide
C25H26N8O3
 1
1
IC50 = 199.53 nM
   TI
   LI
   LO
   TS
CP0412937
[4-(1H-imidazole-5-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C23H20N10O2
 1
1
IC50 = 251.19 nM
   TI
   LI
   LO
   TS
CP0492105
N-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]acetamide
   Show/Hide
C16H13N7O
 1
1
IC50 = 251.19 nM
   TI
   LI
   LO
   TS
CP0492106
[4-(oxan-4-yl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H26N8O2
 1
1
IC50 = 251.19 nM
   TI
   LI
   LO
   TS
CP0454456
[4-(3-methylimidazole-4-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H22N10O2
 1
1
IC50 = 398.11 nM
   TI
   LI
   LO
   TS
CP0533477
[4-(pyrimidine-2-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H20N10O2
 1
1
IC50 = 398.11 nM
   TI
   LI
   LO
   TS
CP0432542
piperidin-1-yl-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C20H19N7O
 1
1
IC50 = 501.19 nM
   TI
   LI
   LO
   TS
CP0558588
N-(2-methoxyethyl)-4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzamide
   Show/Hide
C18H17N7O2
 1
1
IC50 = 630.96 nM
   TI
   LI
   LO
   TS
CP0454457
piperazin-1-yl-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C19H18N8O
 1
1
IC50 = 794.33 nM
   TI
   LI
   LO
   TS
CP0447257
N-(4-chlorophenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C14H9ClN6
 1
1
IC50 = 1258.93 nM
   TI
   LI
   LO
   TS
CP0447258
4-N,4-N-dimethyl-1-N-(tetrazolo[1,5-a]quinoxalin-4-yl)benzene-1,4-diamine
   Show/Hide
C16H15N7
 1
1
IC50 = 1258.93 nM
   TI
   LI
   LO
   TS
CP0565590
N-(4-methylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C15H12N6
 1
1
IC50 = 1258.93 nM
   TI
   LI
   LO
   TS
CP0425188
MLS000686692
   Show/Hide
C14H10N6
 1
1
IC50 = 1995.26 nM
   TI
   LI
   LO
   TS
CP0492104
N-(4-fluorophenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C14H9FN6
 1
1
IC50 = 3981.07 nM
   TI
   LI
   LO
   TS
CP0432543
cyclopropyl-[4-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoyl]piperazin-1-yl]methanone
   Show/Hide
C23H22N8O2
 1
1
IC50 = 5011.87 nM
   TI
   LI
   LO
   TS
CP0358921
N-(3-methylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C15H12N6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0393904
N-(3-propan-2-ylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C17H16N6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0447058
morpholin-4-yl-[3-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C19H17N7O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0454434
[3-fluoro-4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]-morpholin-4-ylmethanone
   Show/Hide
C19H16FN7O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0458578
N-(2-methylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine
   Show/Hide
C15H12N6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0458580
4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoic acid
   Show/Hide
C15H10N6O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0053018
2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano-[4,3-d]pyrimidin-4-ol
   Show/Hide
C14H11F3N2OS
 9
1 IC50 = 1.9 nM
2 IC50 = 10 nM
3 IC50 = 11 nM
4 IC50 = 11.1 nM
5 IC50 = 13 nM
6 IC50 = 15 nM
7 IC50 = 17 nM
8 IC50 = 68 nM
9 Kd = 100 nM
CP0251373
2-(4-tert-butylphenyl)-3H-quinazolin-4-one
   Show/Hide
C18H18N2O
 1
1 IC50 = 5 nM
CP0154599
(4-pyrimidin-2-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C23H20N10O
 1
1 IC50 = 15.85 nM
CP0154554
[4-(1-methylimidazole-4-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H22N10O2
 1
1 IC50 = 31.62 nM
CP0092236
2-Phenyl-3H-quinazolin-4-one
   Show/Hide
C14H10N2O
 2
1 IC50 = 59 nM
2 IC50 = 1406 nM
CP0040799
2-(4-Methoxy-phenyl)-quinazolin-4-ol
   Show/Hide
C15H12N2O2
 2
1 IC50 = 67 nM
2 IC50 = 250 nM
CP0120515
4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one
   Show/Hide
C24H23FN4O3
 3
1 IC50 = 1500 nM
2 IC50 = 1568 nM
3 IC50 > 70000 nM
Clinical Information about the Protein
Target 1 ( Tankyrase-1 (TNKS-1) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Ovarian cancer [ICD-11: 2C73]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 PMID27841036-Compound-37 Phase 2
Ovarian cancer
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT01425 Poly [ADP-ribose] polymerase tankyrase-2 Homo sapiens, Human